DatChat Messenger | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

284 results for “DatChat Messenger”

Trials

View all 74 →

Trusted Messenger Intervention

2 participants · First posted Dec 22, 2021

Major Depression and Messenger RNAs

30 participants · First posted Oct 20, 2009

PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)

75 participants · First posted May 11, 2020

Drugs

1 methylpseudouridine-modified messenger RNA(The Johannes Gutenberg University of Mainz)

SK Japanese Encephalitis MRNA Vaccines(Sk Bioscience)

mRNA modulators (Novation Pharmaceuticals)

Organizations

CureVac

Tempest Minerals Ltd

News

View all 201 →

DatChat Secures European Patent Allowance for Advanced Digital Privacy Technology

AbbVie Acquires In Vivo CAR-T Developer Capstan Therapeutics for Up to $2.1 Billion

FDA Approves Orzeyful (oveporexton), First Orexin Agonist for Narcolepsy Type 1

Page 1 of 29